Evidence map›Paper›PMID 41113325›Full record

ArticleOpen forum infectious diseases2025

Carbapenem-Resistant Organisms in Companion Animals in New York City, 2019-2022.

Caroline A Habrun, William G Greendyke, Donald Szlosek, Andy Plum, Molly M Kratz, Elise Mantell, Karen A Alroy

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Caroline A HabrunNew York City Department of Health and Mental Hygiene, Bureau of Communicable Diseases, New York City, New York, USA.ORCID https://orcid.org/0000-0001-9637-1938
William G GreendykeNew York City Department of Health and Mental Hygiene, Bureau of Communicable Diseases, New York City, New York, USA.
Donald SzlosekIDEXX Laboratories, Westbrook, Maine, USA.
Andy PlumIDEXX Laboratories, Westbrook, Maine, USA.
Molly M KratzNew York City Department of Health and Mental Hygiene, Bureau of Communicable Diseases, New York City, New York, USA.
Elise MantellNew York City Department of Health and Mental Hygiene, Bureau of Communicable Diseases, New York City, New York, USA.
Karen A AlroyNew York City Department of Health and Mental Hygiene, Bureau of Communicable Diseases, New York City, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant organisms (CROs) are a type of antibiotic-resistant bacteria that threaten human health. They can infect or colonize dogs and cats, with potential for zoonotic transmission to humans, but their prevalence in pet populations is not well described. To characterize CRO prevalence among gram-negative cultured isolates from New York City dogs and cats, we analyzed antimicrobial susceptibility data from a commercial veterinary diagnostic laboratory serving New York City veterinarians during 2019-2022. Among 16 115 gram-negative isolates, 256 (1.6%) were CROs cultured from 241 dogs and cats. CRO detections and the percentage positivity fluctuated during 2019-2022 and differed across the city's 5 boroughs. Data sharing between public health and veterinary diagnostic laboratories can identify CROs in pets and create opportunities to improve veterinary outreach and control of CROs in companion animals.

Indexed as

antimicrobial resistancecarbapenem resistancecompanion animalsCROsNew York city

Identifiers

PMID41113325
PMCPMC12534726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.